Skip to content

Strategic Advisors

Webster K. Cavenee, Ph.D.

Director of Strategic Alliances, Ludwig Institute for Cancer Research
Since 2015, Dr. Cavenee is Director, Strategic Alliances-CNS of Ludwig Cancer Research with global responsibilities. He is also Distinguished Professor of Medicine at the University of California, San Diego.
Read More

Pamela Garzone, Ph.D.

Chief Development Officer, Anixa Biosciences
Pamela Garzone, Ph.D., joined Calibr as Chief Medical Officer in May 2019, bringing decades of clinical research experience, spanning large pharmaceutical companies, biotech startups and academia...
Read More

Chih-Kao Hu, Ph.D., MBA

Management Consultant, Qral Group

Chih-Kao is an experienced management consultant working with top 100 pharmaceutical and biotech companies across more than 50 countries. His consulting approach concentrates in providing evidence-based commercialization strategies to healthcare…

Read More

Raju Kucherlapati, Ph.D.

Paul C. Cabot Professor of Genetics, Professor of Medicine, Harvard Medical School
Since 2001 Dr. Kucherlapati is the Paul C. Cabot Professor of Genetics and Professor of Medicine at Harvard Medical School and was the first...
Read More

Lou Lieto, Ph.D., J.D.

Partner, Wilson Sonsini

Dr. Louis D. Lieto is the leader of the patents and innovations department at Wilson Sonsini Goodrich & Rosati and is a partner in the firm’s Boston office. Lou advises…

Read More

Scott Lippman, M.D.

Distinguished Professor of Medicine & Associate Vice Chancellor for Cancer Research, UC San Diego Health

Scott M. Lippman, MD, is a Distinguished Professor of Medicine & Associate Vice Chancellor for Cancer Research at UC San Diego Health, professor of Medicine at UC San Diego School…

Read More

Jimmy Lu, J.D., MBA

Co-Founder & Managing Director, Eos BioInnovation

Mr. Jimmy Lu has over 25+ years of high tech and venture capital experience. Having a background in technology investing, he focuses much of his time now on healthcare related…

Read More

Patty Obermaier

Vice President, US Health and Life Sciences, Microsoft
Patty Obermaier leads Microsoft’s US sales strategy for driving digital transformation across customers and partners within the health and life sciences marketplace.
Read More

Program Advisors

Tonino Belmonte

Founder & Venture Partner, Carthona Capital
Tonino has 36 years of global experience in venture capital, private equity, and capital markets across multiple sectors
Read More

Carlo M. Croce, M.D.

Professor of Internal Medicine, The Ohio State University

Dr. Croce entered the school of medicine of La Sapienza University of Rome and graduated in 1969 summa cum laude in medicine and Latin.  He began his career in the…

Read More

Aleksandra Filipovic, M.D., Ph.D.

Head of Oncology, PureTech Health

Aleksandra Filipovic MD, PhD, is head of oncology at PureTech, where she manages Oncology Asset Sourcing, review of oncology/ immuno oncology technologies and platforms from academia world-wide as well as…

Read More

Dimitra Georganopoulou, Ph.D.

General Partner, Qral Ventures

Dimitra is an experienced biotech professional with deep knowledge of personalized medicine projects, therapeutics. medical devices, diagnostics, and Health IT. Dimitra is a general partner of Qral Ventures, and serves…

Read More

Jennifer Grandis, M.D.

American Cancer Society Professor, University of California San Francisco

Dr. Jennifer Grandis is an otolaryngologist and associate vice chancellor for clinical and translational research at UCSF. She directs the Clinical and Translational Science Institute, which provides resources and builds…

Read More

Beverly Lu, Ph.D.

Investment Manager, Health, Emerson Collective

Beverly Lu is a Biotech VC Investment Manager at Emerson Collective. Prior to joining Emerson, Beverly was a Director at Amgen, responsible for driving strategy and operations of the US…

Read More

Amy Millman

President & Co-Founder, Springboard Enterprises
Amy Millman is a passionate advocate for women entrepreneurs building Big Businesses Starting Small. In 2000, Amy co-founded Springboard Enterprises ...
Read More

Gregory W. Mitchell, Ph.D., J.D.

Senior Counsel, Wilson Sonsini

Greg Mitchell is senior counsel at Wilson Sonsini Goodrich & Rosati. His expertise includes developing and implementing patent strategies, patent prosecution, and patent diligence (both buy and sell side) for…

Read More

Eifion Phillips, Ph.D., J.D.

Patent Attorney
A medicinal chemistry scientist turned patent attorney, Dr. Eifion Phillips has helped secure his clients’ intellectual property portfolios across various fields and innovations...
Read More

Kanaga Sabapathy, Ph.D.

Head, Division of Cellular and Molecular Research, National Cancer Center Singapore
Dr. Sabapathy obtained his Ph.D. in Molecular and Cellular Immunology from the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore, in 1995.
Read More

Michael Salgaller, Ph.D.

Supervisory Invention Development & Marketing Specialist, National Institutes of Health/National Cancer Institute

Dr. Michael Salgaller leads the Invention Development and Marketing Unit within the National Cancer Institute’s Technology Transfer Center, where he leverages over 20 years of business, scientific, and investment experience…

Read More

Paul Schimmel, Ph.D.

Professor, Department of Cell and Molecular Biology, The Scripps Research Institute
Paul Schimmel, Ph.D., is a biophysical chemist and he received his B.A. in biochemistry and biophysics from Ohio Wesleyan University in 1962...
Read More

Fei Shen, Ph.D.

Managing Director, Boehringer Ingelheim Venture Fund USA

Fei is an Investment Director in the Boehringer Ingelheim Corporate Venture Fund. She joined the Boehringer Ingelheim Venture Fund in 2020 and is located in Boston, MA. Fei received her…

Read More

Thea Tlsty, Ph.D.

Professor of Pathology, University of California San Francisco

Dr. Thea Tlsty is Professor of Pathology at the University of California, San Francisco. She is known for her research in cancer biology, and her involvement in the discovery of…

Read More

Daniel D. Von Hoff M.D., F.A.C.P.

Physician-in-Chief & Distinguished Professor, Translational Genomics Research Institute
Daniel D. Von Hoff, M.D., F.A.C.P. FASCO, FAACR is currently Physician in Chief, Distinguished Professor at the Translational Genomics Research Institute (TGen) in Phoenix, Arizona.
Read More

Barbara Weber, M.D.

President & CEO, Tango Therapeutics

Barbara is President and CEO of Tango Therapeutics, a biotechnology company she began building shortly after joining Third Rock Ventures (TRV) in March 2015.  Tango launched with a $55M Series…

Read More
Back To Top